Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 301 of 6351
-
Radioactive beads take aim at inoperable liver tumors
Disease control Not yet recruitingThis is a prospective, single-blinded, single-arm, open-label Phase II trial of trans-arterial radiation segmentectomy using Yttrium-90 glass microspheres (TheraSphere®) for Hepatocellular Carcinoma (HCC) participants with unresectable Barcelona clinic liver cancer (BCLC) stage A…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a simple anesthetic injection during surgery stop Triple-Negative breast cancer from coming back?
Disease control Not yet recruitingBreast cancer is one of the most common cancers among women. One in eight women in France will develop breast cancer during their lifetime (Inca). In 2023, 61,214 new cases of breast cancer were diagnosed in France, and in 2018, 12,146 deaths were attributed to this disease (e-ca…
Phase 2 • Sponsor: Institut Jean-Godinot • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Personalized brain zaps aim to boost stroke recovery in major trial
Disease control Not yet recruitingThis Phase 3 study will evaluate whether lesion network mapping-guided continuous theta burst stimulation (cTBS) can improve recovery after acute ischemic stroke. The treatment uses each participant's brain imaging to identify individualized stimulation targets related to stroke …
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New drug combo targets Tough-to-Treat myeloma
Disease control Not yet recruitingThis is a single-arm, open-label study to evaluate the efficacy and safety of CM336 combined with SOC therapy in patients with dynamically high-risk multiple myeloma.
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a tailored diet make a MASH drug work better?
Disease control Not yet recruitingThis randomized control trial aims to evaluate the effectiveness of combining resmetirom therapy (first approved pharmacological therapy for treating metabolic dysfunction-associated steatohepatitis (MASH)) with a nutritional intervention compared to resmetirom therapy alone over…
Phase 4 • Sponsor: City University of New York • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a smartphone app replace the gym for diabetes control?
Disease control Not yet recruitingType 2 diabetes (T2D) and obesity are two of the most common chronic conditions worldwide, and they frequently occur together. Both conditions are closely linked to physical inactivity, which is currently recognized as a major risk factor for a wide range of diseases. Although st…
Sponsor: Escuela Universitaria de Osuna • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can an AI spot a heart rhythm disorder two hours before it happens?
Diagnosis Not yet recruitingThe purpose of this retrospective study is to evaluate the clinical performance of SMD-AFECG, an artificial intelligence-based medical device software that predicts the risk of atrial fibrillation occurring within 2 hours using single-lead electrocardiogram data. A total of 797 e…
Sponsor: HUINNO Co., Ltd • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Can your DNA predict how you respond to a diabetes drug?
Knowledge-focused Not yet recruitingThis research study aims to learn about how the body responds to food through different genetic pathways and how these responses may change during a short course of orforglipron. Orforglipron is an oral glucagon-like peptide-1 (GLP-1) receptor agonist that was approved by the U.S…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Could cutting dialysis sessions in half improve life for seniors?
Disease control Not yet recruitingMany people who have kidney failure require hemodialysis treatments to stay alive. Hemodialysis is a procedure that cleans the blood of the toxins and fluids that build up when kidneys don't work. Most patients receive hemodialysis treatment three times every week and each treatm…
Sponsor: Queen's University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a new heart valve offer lasting relief for pulmonary stenosis?
Disease control Not yet recruitingThe purpose of the study is to determine the long-term follow-up clinical outcomes, effectiveness, and safety data of the PULSTA Transcatheter Pulmonary Valve (TPV) implantation in a real-world situation
Sponsor: Taewoong Medical Co., Ltd. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a common painkiller sabotage your knee treatment?
Disease control Not yet recruitingThe goal of this randomized clinical trial is to learn whether taking ibuprofen, a nonsteroidal anti-inflammatory drug, after a platelet-rich plasma (PRP) injection changes pain relief and knee function in adults with knee osteoarthritis. The main questions it aims to answer are…
Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a wearable posture coach ease back pain and stiffness?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether adding a wearable postural biofeedback device to a standard exercise program affects disease activity, pain, and functional parameters in individuals with axial spondyloarthritis. The main questions it aims to answer are: Does …
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Could better phone training save more cardiac arrest victims?
Disease control Not yet recruitingEach year, France's emergency response services-the SAMU (15) and the fire department (18)-handle 31 million and 19 million calls, respectively. The effectiveness of this system depends on the call centers' ability to obtain location information, prioritize responses, assess the …
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a Two-Drug chemo combo outsmart resistant tumors?
Disease control Not yet recruitingPhase I trial, Multiple centers, open-label, non-randomized single-arm study
Phase 1 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A simple care plan may shield older brains after surgery
Prevention Not yet recruitingPostoperative delirium is a common complication in older adults undergoing surgery. It is characterized by an acute and fluctuating disturbance of attention, awareness, and thinking. Delirium may be associated with prolonged hospital stay, loss of independence, cognitive decline,…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Could a health Worker's support break the smoking habit in mental illness?
Disease control Not yet recruitingThe purpose of this study is to learn whether providing additional smoking cessation support through specially trained members of behavioral healthcare team helps people quit smoking and improve their health. Participants ages 18-75 who receive mental health services and smoke ci…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can the immune system explain brain and psychiatric symptoms?
Knowledge-focused Not yet recruitingThe goal of this observational cohort study is to investigate the role of immune system in neuropsychiatric symptoms (NPS) and to identify immunological biomarkers that may improve the diagnosis, prognosis, and future treatment of immune-related neuropsychiatric disorders in indi…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can engineered immune cells tame a stubborn autoimmune disease?
Disease control Not yet recruitingThis is an investigator initiated trial to assess the safety and efficacy of BCT301 cell Injection (CAR-iT cells derived from chemically induced pluripotent stem cells) in patients with refractory/recurrent IgG4-related disease.
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Talking through memories may lighten the load for dementia caregivers
Symptom relief Not yet recruitingThe purpose of this study is to evaluate the efficacy of Dyadic Life Review (DLR) therapy for reducing caregiver distress, measured by caregiver burden to capture the multifaceted experience of distress, among older adults with advanced cancer and cognitive impairment and their c…
Sponsor: University of Rochester • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can 10 minutes of breathing ease Chemotherapy's toll?
Symptom relief Not yet recruitingThis randomized controlled trial will evaluate the effects of a mobile-delivered remote mindfulness breathing training program on symptom distress, fatigue, anxiety, and depression in adults with cancer who are receiving chemotherapy. A total of 80 participants will be randomly …
Sponsor: Tri-Service General Hospital (TSGH) • Aim: Symptom relief
Last updated Sep 09, 2026 16:00 UTC